MedPlus Health Services Limited
NSE:MEDPLUS.NS
680 (INR) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Revenue
| 56,248.55 | 45,575.76 | 37,553.75 | 30,507.75 | 28,512.52 | 22,588.73 |
| Cost of Revenue
| 52,413.61 | 35,576.88 | 29,823.75 | 24,250.29 | 23,377.86 | 18,451.89 |
| Gross Profit
| 3,834.94 | 9,998.88 | 7,730 | 6,257.46 | 5,134.66 | 4,136.84 |
| Gross Profit Ratio
| 0.068 | 0.219 | 0.206 | 0.205 | 0.18 | 0.183 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 2.09 | 2.47 | 3.02 |
| General & Administrative Expenses
| 6,256.16 | 209.53 | 168.8 | 141.64 | 109.42 | 135.49 |
| Selling & Marketing Expenses
| 252.1 | 677.56 | 473.48 | 292.72 | 377.23 | 351.9 |
| SG&A
| 2,536.26 | 887.09 | 642.28 | 434.36 | 486.65 | 487.39 |
| Other Expenses
| 400.08 | 460.78 | 103.48 | 111.5 | 81.4 | 84.2 |
| Operating Expenses
| 2,536.26 | 9,157.76 | 6,163.84 | 4,970.16 | 4,217.83 | 3,516.72 |
| Operating Income
| 1,298.68 | 960.92 | 1,627.08 | 1,353.19 | 967.8 | 620.12 |
| Operating Income Ratio
| 0.023 | 0.021 | 0.043 | 0.044 | 0.034 | 0.027 |
| Total Other Income Expenses Net
| -564.25 | -489.29 | -447.65 | -402.21 | -674.21 | -392.61 |
| Income Before Tax
| 734.43 | 471.63 | 1,179.43 | 950.98 | 293.59 | 227.51 |
| Income Before Tax Ratio
| 0.013 | 0.01 | 0.031 | 0.031 | 0.01 | 0.01 |
| Income Tax Expense
| 78.66 | -29.42 | 232.27 | 319.87 | 275.65 | 108.29 |
| Net Income
| 654.73 | 497.63 | 958.02 | 638.58 | 21.8 | 119.21 |
| Net Income Ratio
| 0.012 | 0.011 | 0.026 | 0.021 | 0.001 | 0.005 |
| EPS
| 5.48 | 4.17 | 15.97 | 6.26 | 1.05 | 1 |
| EPS Diluted
| 5.45 | 4.16 | 8.55 | 6.13 | 1.01 | 1 |
| EBITDA
| 3,540.82 | 3,122.25 | 3,000.48 | 2,346.19 | 1,824.63 | 1,306.41 |
| EBITDA Ratio
| 0.063 | 0.069 | 0.08 | 0.077 | 0.064 | 0.058 |